商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CITALOPRAM HYDROBROMIDE | 077141 | 001 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | No | No | 2008/04/10 | 2008/04/10 | NATCO PHARMA LTD | Discontinued |
CITALOPRAM HYDROBROMIDE | 077141 | 002 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | No | No | 2008/04/10 | 2008/04/10 | NATCO PHARMA LTD | Discontinued |
CITALOPRAM HYDROBROMIDE | 077654 | 001 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 10MG BASE | No | No | 2009/02/27 | 2009/02/27 | GLENMARK PHARMS LTD | Prescription |
CITALOPRAM HYDROBROMIDE | 077654 | 002 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | No | No | 2009/02/27 | 2009/02/27 | GLENMARK PHARMS LTD | Prescription |
CITALOPRAM HYDROBROMIDE | 077654 | 003 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | No | No | 2009/02/27 | 2009/02/27 | GLENMARK PHARMS LTD | Prescription |
CITALOPRAM HYDROBROMIDE | 201450 | 001 | ANDA | CITALOPRAM HYDROBROMIDE | SOLUTION;ORAL | EQ 10MG BASE/5ML | No | No | 2015/12/15 | 2015/12/15 | HETERO LABS LTD III | Prescription |
CITALOPRAM HYDROBROMIDE | 205407 | 001 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 10MG BASE | No | No | 2015/12/23 | 2015/12/23 | JUBILANT GENERICS | Discontinued |
CITALOPRAM HYDROBROMIDE | 205407 | 002 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | No | No | 2015/12/23 | 2015/12/23 | JUBILANT GENERICS | Discontinued |
CITALOPRAM HYDROBROMIDE | 205407 | 003 | ANDA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | No | No | 2015/12/23 | 2015/12/23 | JUBILANT GENERICS | Discontinued |
CITALOPRAM HYDROBROMIDE | 215428 | 001 | NDA | CITALOPRAM HYDROBROMIDE | CAPSULE;ORAL | EQ 30MG BASE | Yes | Yes | 2022/01/31 | 2022/01/31 | ALMATICA | Prescription |